Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Nicolay

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
The Journal of Surgical Research|October 12, 2000
Prevention of suture hole bleeding using fibrin sealant: benefits of factor XIIIG Dickneite, H Metzner, U Nicolay
Clinical Nephrology|March 24, 2011
Education for dialysis patients lowers long-term phosphate levels and maintains health-related quality of lifeA Gardulf, M Pålsson, U Nicolay, et al.
Developments in Biological Standardization|December 17, 1998
Monitoring and safety assessment in Phase I to III clinical trialsR Fescharek, U Nicolay, C Arras-Reiter
Haemostasis|July 1, 1996
Influence of recombinant hirudin on tissue-factor-induced activation of coagulation in rabbitsJ Kouz, J Czech, U Nicolay, et al.
Cancer|May 15, 1991
Interleukin-3. Biologic effects and clinical impactW Oster, J Frisch, U Nicolay, et al.
Thrombosis and Haemostasis|July 31, 1998
Development of an anti-bleeding agent for recombinant hirudin induced skin bleeding in the pigG Dickneite, U Nicolay, H J Friesen, et al.
Clinical Immunology (Orlando, Fla.)|October 30, 2007
Prognostic factors for health-related quality of life in adults and children with primary antibody deficiencies receiving SCIG home therapyA Gardulf, M Borte, H D Ochs, et al.
American Journal of Clinical Oncology|January 1, 1991
New therapeutic modalities for the clinical use of rhGM-CSF in patients with malignanciesG Schulz, J Frisch, B Greifenberg, et al.
Vaccine|July 14, 1999
Diphtheria booster vaccination: one or two injections?U Nicolay, O E Girgsdies, A Banzhoff, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 27, 2005
Measuring treatment satisfaction in patients with primary immunodeficiency diseases receiving lifelong immunoglobulin replacement therapyU Nicolay, S Haag, F Eichmann, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Journal of Surgical Research|October 12, 2000
Prevention of suture hole bleeding using fibrin sealant: benefits of factor XIIIG Dickneite, H Metzner, U Nicolay
Clinical Nephrology|March 24, 2011
Education for dialysis patients lowers long-term phosphate levels and maintains health-related quality of lifeA Gardulf, M Pålsson, U Nicolay, et al.
Developments in Biological Standardization|December 17, 1998
Monitoring and safety assessment in Phase I to III clinical trialsR Fescharek, U Nicolay, C Arras-Reiter
Haemostasis|July 1, 1996
Influence of recombinant hirudin on tissue-factor-induced activation of coagulation in rabbitsJ Kouz, J Czech, U Nicolay, et al.
Cancer|May 15, 1991
Interleukin-3. Biologic effects and clinical impactW Oster, J Frisch, U Nicolay, et al.
Thrombosis and Haemostasis|July 31, 1998
Development of an anti-bleeding agent for recombinant hirudin induced skin bleeding in the pigG Dickneite, U Nicolay, H J Friesen, et al.
Clinical Immunology (Orlando, Fla.)|October 30, 2007
Prognostic factors for health-related quality of life in adults and children with primary antibody deficiencies receiving SCIG home therapyA Gardulf, M Borte, H D Ochs, et al.
American Journal of Clinical Oncology|January 1, 1991
New therapeutic modalities for the clinical use of rhGM-CSF in patients with malignanciesG Schulz, J Frisch, B Greifenberg, et al.
Vaccine|July 14, 1999
Diphtheria booster vaccination: one or two injections?U Nicolay, O E Girgsdies, A Banzhoff, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 27, 2005
Measuring treatment satisfaction in patients with primary immunodeficiency diseases receiving lifelong immunoglobulin replacement therapyU Nicolay, S Haag, F Eichmann, et al.
Pageof 2